Primary results of ROSE / TRIO-12, a randomized placebo controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer - Mackey, J R; Ramos-Vazquez, M; Lipatov, O (2013)
SABCS